- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
ViroPharma Incorporated
(NASDAQ:VPHM)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 612,808 | 496,534 | 324,211 | 179,691 |
| Restricted Cash | — | — | — | — |
| Marketable Securities | 55,557 | 136,342 | 274,794 | 404,637 |
| Accounts Receivable | 22,918 | 27,225 | 22,690 | 17,684 |
| Loans Receivable | — | — | — | — |
| Other Receivable | 675 | 1,963 | 3,374 | 5,937 |
| Receivables | 23,593 | 29,188 | 26,064 | 23,621 |
| Raw Materials | 3,088 | — | 3,624 | 3,355 |
| Work in Progress | — | — | — | — |
| Purchased Components | — | — | — | — |
| Finished Goods | 2,053 | — | 1,548 | 1,348 |
| Other Inventories | — | 4,675 | — | — |
| Inventories Adjustments and Allowances | — | — | — | — |
| Inventories | 5,141 | 4,675 | 5,172 | 4,703 |
| Prepaid Expenses | 1,096 | 5,109 | 6,493 | 2,138 |
| Current Deferred Income Taxes | 1,008 | 2,892 | 7,277 | 7,983 |
| Other Current Assets | — | — | — | — |
| Total Current Assets | 699,203 | 674,740 | 644,011 | 622,773 |
| Land and Improvements | — | — | — | 380 |
| Building and Improvements | — | — | — | 9,410 |
| Machinery Furniture and Equipment | — | — | — | 3,576 |
| Construction in Progress | — | — | — | — |
| Other Fixed Assets | 16,919 | 14,325 | 14,154 | — |
| Total Fixed Assets | 16,919 | 14,325 | 14,154 | 13,366 |
| Gross Fixed Assets | 16,919 | 14,325 | 14,154 | 13,366 |
| Accumulated Depreciation and Depletion | 2,476 | 2,476 | 2,476 | 2,476 |
| Net Fixed Assets | 14,443 | 11,849 | 11,678 | 10,890 |
| Intangibles | 124,197 | 125,668 | 122,891 | 122,502 |
| Cost in Excess | — | — | — | — |
| Non Current Deferred Income Taxes | 7,243 | 6,133 | 8,146 | 12,312 |
| Other Non Current Assets | 9,438 | 7,608 | 7,386 | 7,589 |
| Total Non Current Assets | 155,321 | 151,258 | 150,101 | 153,293 |
| Total Assets | 854,524 | 825,998 | 794,112 | 776,066 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 4,497 | 1,809 | 2,038 | 2,017 |
| Notes Payable | — | — | — | — |
| Short Term Debt | — | — | — | — |
| Accrued Expenses | 21,493 | 27,493 | 21,447 | 18,687 |
| Accrued Liabilities | — | — | — | — |
| Deferred Revenues | — | — | — | — |
| Current Deferred Income Tax Liabilities | — | — | — | — |
| Other Current Liabilities | 1,441 | 1,441 | 1,066 | 7,666 |
| Total Current Liabilities | 27,431 | 30,743 | 24,551 | 28,370 |
| Non Current Liabilities | ||||
| Long Term Debt | 250,000 | 250,000 | 250,000 | 250,000 |
| Capital Lease Obligations | — | — | — | — |
| Deferred Income Tax Liabilities | — | — | — | — |
| Other Non Current Liabilities | 2,919 | 2,171 | 2,131 | 1,133 |
| Minority Interest Liabilities | — | — | — | — |
| Preferred Securities of Subsidiary Trust Liabilities | — | — | — | — |
| Preferred Equity Outside Stock Equity | — | — | — | — |
| Total Non Current Liabilities | 280,350 | 282,914 | 276,682 | 279,503 |
| Total Liabilities | 252,919 | 252,171 | 252,131 | 251,133 |
| Shareholders' Equity | ||||
| Preferred Stock Equity | — | — | — | — |
| Common Stock Equity | 574,174 | 543,084 | 517,430 | 496,563 |
| Common Par | 140 | 140 | 140 | 140 |
| Additional Paid in Capital | 506,402 | 502,654 | 500,549 | 498,350 |
| Cumulative Translation Adjustment | — | — | — | — |
| Retained Earnings | 67,213 | 40,139 | 16,069 | -1,381 |
| Treasury Stock | — | — | — | — |
| Other Equity Adjustments | 419 | 151 | 672 | -546 |
| Total Capitalization | 824,174 | 793,084 | 767,430 | 746,563 |
| Cash Flow | 96,625 | 90,864 | 98,099 | 102,277 |
| Working Capital | 671,772 | 643,997 | 619,460 | 594,403 |
| Free Cash Flow | 88,504 | 49,705 | 13,332 | 108,051 |
| Invested Capital | 824,174 | 793,084 | 767,430 | 746,563 |
| Total Equity | 574,174 | 543,084 | 517,430 | 496,563 |
| Total Liabilities and Stock Equity | 854,524 | 825,998 | 794,112 | 776,066 |